Sylvain Thierry

Carotenoids: biochemistry, pharmacology and treatment

Assessment of network perturbation amplitudes by applying high-throughput data to causal biological networks

Inhibitory effects of lycopene on HMGB1-mediated pro-inflammatory responses in both cellular and animal models

The promise and challenge of therapeutic genome editing

Ferroptosis: molecular mechanisms and health implications

Phospholipase A2 subclasses in acute respiratory distress syndrome

An Acquired and Endogenous Glycocalyx Forms a Bidirectional “Don’t Eat” and “Don’t Eat Me” Barrier to Phagocytosis

S100B/RAGE-dependent activation of microglia via NF-κB and AP-1

Phagocytosis checkpoints as new targets for cancer immunotherapy

HIV-1 Integrase Inhibitor Resistance and Its Clinical Implications

Membrane Prostaglandin E Synthase-1: A Novel Therapeutic Target

CRISPR–Cas9 genome engineering of primary CD4+ T cells for the interrogation of HIV–host factor interactions

The molecular machinery of regulated cell death

Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders

A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human T Cells

The immune system in atherosclerosis

HMGB1 in health and disease

Small-Molecule Library Screening by Docking with PyRx

The Beclin 1 network regulates autophagy and apoptosis

A Dynamic Model of HIV Integrase Inhibition and Drug Resistance

Glycyrrhizin Binds to High-Mobility Group Box 1 Protein and Inhibits Its Cytokine Activities

High-Mobility Group Box 1, Oxidative Stress, and Disease

Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein

Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective

Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas

Lipoprotein-Associated and Secreted Phospholipases A ₂ in Cardiovascular Disease

Ion transporters in brain endothelial cells that contribute to formation of brain interstitial fluid

Causal analysis approaches in Ingenuity Pathway Analysis

Prostaglandins and Inflammation

Phospholipase A₂Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention

DAMPs, PAMPs and alarmins: all we need to know about danger

Micronuclei Frequency in Tumors Is a Predictive Biomarker for Genetic Instability and Sensitivity to the DNA Repair Inhibitor AsiDNA

Impact of the Ku Complex on HIV-1 Expression and Latency

Impact of Y143 HIV-1 Integrase Mutations on Resistance to Raltegravir In Vitro and In Vivo

Activation of sPLA2‐IIA and PGE2 production by high mobility group protein B1 in vascular smooth muscle cells sensitized by IL‐1β

Cell Cycle Arrest in G ₂ Induces Human Immunodeficiency Virus Type 1 Transcriptional Activation through Histone Acetylation and Recruitment of CBP, NF-κB, and c-Jun to the Long Terminal Repeat Promoter